|
1
|
Chin L, Garraway LA and Fisher DE:
Malignant melanoma: Genetics and therapeutics in the genomic era.
Genes Dev. 20:2149–2182. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lakshmikanth T and Johansson MH: Current
perspectives on immunomodulation of NK cells in melanoma. Melanoma
in the Clinic - Diagnosis. Management and Complications of
Malignancy; Mandi M: InTech, Rijeka: pp. 133–162. 2011
|
|
3
|
Serban ED, Farnetani F, Pellacani G and
Constantin MM: Role of in vivo reflectance confocal microscopy in
the analysis of melanocytic lesions. Acta Dermatovenerol Croat.
26:64–67. 2018.PubMed/NCBI
|
|
4
|
Rangwala S and Tsai KY: Roles of the
immune system in skin cancer. Br J Dermatol. 165:953–965. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lupu M, Caruntu A, Caruntu C, Papagheorghe
LML, Ilie MA, Voiculescu V, Boda D, Constantin C, Tanase C, Sifaki
M, et al: Neuroendocrine factors: The missing link in non-melanoma
skin cancer (Review). Oncol Rep. 38:1327–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Caruntu C, Boda D, Constantin C, Caruntu A
and Neagu M: Catecholamines increase in vitro proliferation of
murine B16F10 melanoma cells. Acta Endocrinol (Copenh). 10:545–558.
2014.
|
|
7
|
Neagu M: The immune system - a hidden
treasure for biomarker discovery in cutaneous melanoma. Adv Clin
Chem. 58:89–140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holtan SG, Creedon DJ, Thompson MA, Nevala
WK and Markovic SN: Expansion of CD16-negative natural killer cells
in the peripheral blood of patients with metastatic melanoma. Clin
Dev Immunol. 2011:3163142011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Imai K, Matsuyama S, Miyake S, Suga K and
Nakachi K: Natural cytotoxic activity of peripheral-blood
lymphocytes and cancer incidence: An 11-year follow-up study of a
general population. Lancet. 356:1795–1799. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dons'koi BV, Chernyshov VP and Osypchuk
DV: Measurement of NK activity in whole blood by the CD69
upregulation after co-incubation with K562, comparison with NK
cytotoxicity assays and CD107a degranulation assay. J Immunol
Methods. 372:187–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fehniger TA, Cooper MA, Nuovo GJ, Cella M,
Facchetti F, Colonna M and Caligiuri MA: CD56bright
natural killer cells are present in human lymph nodes and are
activated by T cell-derived IL-2: A potential new link between
adaptive and innate immunity. Blood. 101:3052–3057. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Colucci F, Caligiuri MA and Di Santo JP:
What does it take to make a natural killer? Nat Rev Immunol.
3:413–425. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ursaciuc C, Surcel M, Huică R, Ciotaru D,
Dobre M, Pîrvu IR, Cirimbei C, Mischianu D, Bratu O, Isvoranu G, et
al: CD56dim/CD56bright NK cell subpopulations
and CD16/CD57 expression correlated with tumor development stages.
S East Eur J Immunol. 2016:1–5. 2016. View Article : Google Scholar
|
|
14
|
Hayakawa Y and Smyth MJ: CD27 dissects
mature NK cells into two subsets with distinct responsiveness and
migratory capacity. J Immunol. 176:1517–1524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inngjerdingen M, Kveberg L, Naper C and
Vaage JT: Natural killer cell subsets in man and rodents. Tissue
Antigens. 78:81–88. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun JC and Lanier LL: NK cell development,
homeostasis and function: Parallels with CD8+ T cells.
Nat Rev Immunol. 11:645–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chiossone L, Chaix J, Fuseri N, Roth C,
Vivier E and Walzer T: Maturation of mouse NK cells is a 4-stage
developmental program. Blood. 113:5488–5496. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
National Research Council: Animal care and
use program. In: Guide for the Care and Use of Laboratory Animals.
8th. National Academy Press; Washington, DC: pp. 11–35. 2011
|
|
19
|
Faustino-Rocha A, Oliveira PA,
Pinho-Oliveira J, Teixeira-Guedes C, Soares-Maia R, da Costa RG,
Colaço B, Pires MJ, Colaço J, Ferreira R and Ginja M: Estimation of
rat mammary tumor volume using caliper and ultrasonography
measurements. Lab Animal. 42:217–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Freud AG, Zhao S, Wei S, Gitana GM,
Molina-Kirsch HF, Atwater SK and Natkunam Y: Expression of the
activating receptor, NKp46 (CD335), in human natural killer and
T-cell neoplasia. Am J Clin Pathol. 140:853–866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hadad U, Thauland TJ, Martinez OM, Butte
MJ, Porgador A and Krams SM: NKp46 clusters at the immune synapse
and regulates NK cell polarization. Front Immunol. 6:4952015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
North J, Bakhsh I, Marden C, Pittman H,
Addison E, Navarrete C, Anderson R and Lowdell MW: Tumor-primed
human natural killer cells lyse NK-resistant tumor targets:
Evidence of a two-stage process in resting NK cell activation. J
Immunol. 178:85–94. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iizuka K, Chaplin DD, Wang Y, Wu Q, Pegg
LE, Yokoyama WM and Fu YX: Requirement for membrane lymphotoxin in
natural killer cell development. Proc Natl Acad Sci USA.
96:6336–6340. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fogel LA, Sun MM, Geurs TL,
Carayannopoulos LN and French AR: Markers of nonselective and
specific NK cell activation. J Immunol. 190:6269–6276. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Burt BM, Plitas G, Stableford JA, Nguyen
HM, Bamboat ZM, Pillarisetty VG and DeMatteo RP: CD11c identifies a
subset of murine liver natural killer cells that responds to
adenoviral hepatitis. J Leukoc Biol. 84:1039–1046. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Blasius AL, Barchet W, Cella M and Colonna
M: Development and function of murine
B220+CD11c+NK1.1+ cells identify
them as a subset of NK cells. J Exp Med. 204:2561–2568. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Michel T, Poli A, Cuapio A, Briquemont B,
Iserentant G, Ollert M and Zimmer J: Human CD56bright NK
cells: An update. J Immunol. 196:2923–2931. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Richards JO, Chang X, Blaser BW, Caligiuri
MA, Zheng P and Liu Y: Tumor growth impedes natural-killer-cell
maturation in the bone marrow. Blood. 108:246–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clinthorne JF, Beli E, Duriancik DM and
Gardner EM: NK cell maturation and function in C57BL/6 mice are
altered by caloric restriction. J Immunol. 190:712–722. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huntington ND, Tabarias H, Fairfax K,
Brady J, Hayakawa Y, Degli-Esposti MA, Smyth MJ, Tarlinton DM and
Nutt SL: NK cell maturation and peripheral homeostasis is
associated with KLRG1 upregulation. J Immunol. 178:4764–4770. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ballas ZK, Buchta CM, Rosean TR, Heusel JW
and Shey MR: Role of NK cell subsets in organ-specific murine
melanoma metastasis. PLoS One. 8:e655992013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alter G, Malenfant JM and Altfeld M:
CD107a as a functional marker for the identification of natural
killer cell activity. J Immunol Methods. 294:15–22. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Neagu M, Constantin C and Longo C:
Chemokines in the melanoma metastasis biomarkers portrait. J
Immunoassay Immunochem. 36:559–566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Neagu M, Constantin C and Tanase C:
Immune-related biomarkers for diagnosis/prognosis and therapy
monitoring of cutaneous melanoma. Expert Rev Mol Diagn. 10:897–919.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neagu M, Caruntu C, Constantin C, Boda D,
Zurac S, Spandidos DA and Tsatsakis AM: Chemically induced skin
carcinogenesis: Updates in experimental models (Review). Oncol Rep.
35:2516–2528. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zurac S, Neagu M, Constantin C, Cioplea M,
Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et
al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in
cutaneous melanoma with regression and their possible function as
prognostic predictors. Oncol Lett. 11:3354–3360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Isvoranu G, Marinescu B, Surcel M,
Ursaciuc C and Manda G: Immunotherapy in cancer - in vivo study of
the anti-tumor activity of the IL-15/IL-15R alfa combination in an
experimental model of melanoma. Farmacia. 63:631–636. 2015.
|
|
38
|
Isvoranu G: The memory activation of NK
cells: New methods in cancer immunotherapy. Immunotherapy: Myths,
Reality, Ideas, Future. Metodiev K: IntechOpen, London: pp.
201–219. 2017
|
|
39
|
Zaharescu I, Moldovan AD and Tanase C:
Natural killer (NK) cells and their involvement in different types
of cancer. Current status of clinical research. J Mind Med Sci.
4:31–37. 2017. View Article : Google Scholar
|
|
40
|
Tanase CP, Albulescu R and Neagu M:
Application of 3D hydrogel microarrays in molecular diagnostics:
Advantages and limitations. Expert Rev Mol Diagn. 11:461–464. 2011.
View Article : Google Scholar : PubMed/NCBI
|
